| January 3 |
Human H5N1 Virus Replikin Count Overtakes That in H5N1 Bird Flu |
| January 3 |
Drug Improves Tremors, Involuntary Movements in Parkinson Patients |
| January 3 |
Medication Does Not Appear to Offer Benefit for Certain Heart Attack Patients Undergoing Angioplasty or Stent Procedure |
| January 4 |
Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled Aerovant in Asthma Patients |
| January 4 |
New Details on How the Immune System Recognizes Influenza |
| January 4 |
Molecular Crosstalk Between Tumor and Surrounding Cells Marks Cancer Progression |
| January 4 |
MGI Pharma Announces Publication of Phase 2 Data Describing Dacogen (Decitabine) for Injection in Blood |
| January 4 |
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients |
| January 4 |
New Study Reports Preclinical Findings Involving Celsion Heat Activated Liposome |
| January 5 |
Schwarz Pharma Announces Publication of Rotigotine Data in Neurology |
| January 5 |
Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005 |
| January 5 |
Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs |
| January 6 |
Genentech Announces Positive Results From a Randomized Phase II Study of Pertuzumab in Combination With Gemcitabine for Advanced Ovarian Cancer |
| January 6 |
Hypnion Announces Positive and Robust Phase II Results for Novel Sleep Drug - HY10275 |
| January 9 |
ImClone Systems to Disclose the Result of a Phase III Study before End of Week |
| January 9 |
Incyte to Report Positive Preliminary Clinical Results from HIV and Diabetes Programs and Highlight Progress in Several Drug Development Programs at the 25th JPMorgan Healthcare Conference |
| January 9 |
Dynavax Reports Interim Tolamba Ragweed Allergy Results From DARTT Trial |
| January 9 |
XenoPort Announces Advancements in Clinical Development Programs |
| January 9 |
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of Fentora in Breakthrough Pain |
| January 9 |
QuatRx Pharmaceuticals Reports Positive Results From a Phase 2 Trial of Fispemifene |
| January 9 |
Myriad Genetics Announces Results of Phase 2 Prostate Cancer Trial |
| January 9 |
ProtoKinetix Highlights AAGP Development and Production Strategy |
| January 9 |
ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate |
| January 9 |
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis |
| January 9 |
Quigley's Broad Spectrum Anti-Viral QR-441(a) Shown to Be Effective Against Two Problematic Pathogens to the Poultry Industry |
| January 9 |
Herceptin Improves Early Survival for Women with Breast Cancer |
| January 10 |
ImmuneRegen BioSciences, Inc. Demonstrates That Viprovex Is a Potential Treatment for Avian and Other Influenzas |
| January 10 |
Study Shows Potential of Targeted Microbubbles Using Peregrine's VTA Technology to Identify Which Cancer Patients Would Benefit From Anti-Angiogenesis Therapy |
| January 10 |
The Medicines Company's Cleviprex (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives |
| January 10 |
Benefits of Testosterone Treatment Unknown, Research Shows |
| January 11 |
SemBioSys' Plant-Produced Insulin Chemically and Physiologically Equivalent to Commercial Insulin in Animal Studies |
| January 11 |
Erbitux Meets Primary Endpoint in First-Line Phase III Metastatic Colorectal Cancer Study |
| January 11 |
Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial |
| January 11 |
Erbitux Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer |
| January 11 |
Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference |
| January 11 |
Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference |
| January 11 |
APR Announces Today Successful Phase III Clinical Trial Results for PRO-513 |
| January 11 |
Basilea Announces Positive Top-line Results on Second Pivotal Phase III Ceftobiprole Trial |
| January 12 |
Chelsea Therapeutics Announces Results of European Phase IIb Trial of Droxidopa |
| January 12 |
MultiCell Technologies' Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer |
| January 12 |
Bayer and Onyx Announce Pivotal Nexavar Kidney Cancer Study Published in New England Journal of Medicine |
| January 12 |
New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia |
| January 12 |
New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia |
| January 12 |
Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections |
| January 12 |
Positive Results with Rotigotine in Restless Legs Syndrome in Second Phase III Trial |
| January 12 |
Women's Response to Anti-HIV Therapy Improved if Treatment Begins Six Months After Earlier Preventive Regimen |
| January 13 |
Point Therapeutics Provides Preliminary Results from Phase 2 Metastatic Pancreatic Cancer Study |
| January 13 |
Study in European Heart Journal Favors TAXUS Stent Over Cypher Stent and Bare-Metal Stents in Diabetic Patients |
| January 16 |
Novel Compound Affords Protection Against Lethal, Whole-Body Radiation Even When Administered Hours After Exposure! |
| January 16 |
New Gene Uncovered for Alzheimer Disease |
| January 16 |
Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients With Type 1 Gaucher Disease |
| January 16 |
Actelion Announces Successful Study with Tracleer in Patients with Mildly Symptomatic Pulmonary Arterial Hypertension |
| January 16 |
New Cancer Drug Shown to Be Active in Patients for the First Time |
| January 17 |
Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103 |
| January 17 |
Hollis-Eden Pharmaceuticals Presents Data Demonstrating Discovery of an Endogenous Hormone Potentially Central to Glucose Metabolism |
| January 17 |
ArQule Provides Clinical Trial Update |
| January 17 |
Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria |
| January 17 |
BioMarin Announces Positive Results From Phase 3 Diet Study of Phenoptin for PKU |
| January 17 |
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia |
| January 17 |
Viragen Announces That OVA System Results are Published in Leading U.S. Scientific Journal |
| January 17 |
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia |
| January 17 |
MediciNova Announces Results From a Phase II/III Interstitial Cystitis Trial With MN-001 |
| January 17 |
Combination of Introgen's Nanoparticles Demonstrate Increased Efficacy in the Treatment of Metastatic Lung Cancer |
| January 17 |
African-American Heart Attack Survivors Cite Experience as a 'Wake-Up Call' to Address Health and Life Issues |
| January 17 |
Pivotal Paper in 'The Oncologist' From National Cancer Institute Predicts Doubling of Cancer Patients |
| January 17 |
Study Finds Antivirals Effectively Curb Influenza Virus and Are Valuable in Managing Seasonal Flu in Households |
| January 18 |
Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes |
| January 18 |
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors |
| January 18 |
Metabolex Shows MBX-102/JNJ-39659100 Reduces Inflammation in Preclinical Models of Diabetes |
| January 18 |
Evidence Lacking to Support Many Off-Label Uses of Atypical Antipsychotics |
| January 18 |
Genaera Corporation Announces Presentation of Data on Trodusquemine Mechanism of Action in Obesity |
| January 19 |
Anesiva Announces Clinical Data From Phase 1 Trial of 1207 |
| January 19 |
Protox Reports Promising Interim Results from Prostate Cancer Study |
| January 19 |
Cancer Rates Drop for Second Straight Year; Robust Pipeline of New Medicines Offers Even More Hope |
| January 19 |
Genetic Signature Predicts Recurrence of Breast, Prostate and Other Cancers, Stanford Researchers Find |
| January 19 |
MGI Pharma Announces Publication of Phase 3 Data for Saforis (glutamine) Powder in UpTec for Oral Suspension in Cancer |
| January 19 |
Millenia Hope's HIV-1 RNaseH program |
| January 19 |
Cetuximab May Prolong Survival for Head and Neck Cancer Patients |
| January 19 |
Cetuximab With Radiotherapy Does Not Increase Side Effects for Head and Neck Cancer Patients |
| January 20 |
S-1 Oral Anticancer Agent Improves Patients' Survival In Adjuvant Gastric Cancer Trial Versus Surgery Alone |
| January 20 |
Global Goal to Reduce Measles Deaths in Children Surpassed |
| January 20 |
Statin Plus Cancer Drug Deliver Combo Punch to Brain Cancer Cells |
| January 20 |
Cetuximab May Prolong Survival for Head and Neck Cancer Patients |
| January 20 |
Study Finds Differences between Blood Pressure Medicines and Newly-Diagnosed Diabetes |
| January 20 |
Lifestyle Changes Effective in Protecting Against Type II Diabetes |
| January 23 |
Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer |
| January 23 |
Quigley QR-443 Cachexia Compound Demonstrates Dose Response Effectiveness in Second Preliminary Animal Model Study; Oral Dosing of QR-443 Equally Effective to Intra-Peritoneal Administration in Delaying the Progression of Cachexia in Preliminary Tumor Burden Mouse Model |
| January 23 |
Results Show Xelox (Xeloda plus oxaliplatin) Provides Equivalent Overall Patient Survival Compared to Folfox in Advanced Colorectal Cancer |
| January 23 |
Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic |
| January 23 |
BTG's Plevitrexed Shows Promising Efficacy and Tolerability in a Phase I/II study |
| January 23 |
Bioponic Phytoceuticals Announces That Its Curecumin Product May Be an Effective Treatment for Alzheimer's Disease |
| January 23 |
Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor |
| January 23 |
Chemokine Therapeutics to Present Data at the Annuual Meeting of the American Association For Cancer Research on its Lead Drug Candidate, CTCE-9908 |
| January 23 |
Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Capsaicin-induced Pain |
| January 23 |
New Study Evaluates Communication About Chemotherapy-Induced Anemia and Fatigue in Clinical Settings |
| January 23 |
Callisto Pharmaceuticals Announces Publication of Research Paper on Atiprimod |
| January 23 |
Introgen's ADVEXIN Clinical Biomarker Data Presented at Conference on Licensure of Cell and Gene Therapy Products |
| January 23 |
Welichem's Anti-cancer Drug Candidate Stimulates the Immune System |
| January 23 |
Report Finds Over-the-Counter Drug for Heartburn, Acid Reflux as Effective as Prescription Drugs Costing 10 Times More |
| January 24 |
Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten |
| January 24 |
Publication of Early Research on Callisto Pharmaceutical's Degrasyn Drug Class Suggests Potential to Treat Brain Tumors |
| January 24 |
Clinical Pharmacists Can Positively Contribute to Clinical Outcomes for HIV-Infected Patients |
| January 24 |
New Data Support Novavax's Pandemic Flu Vaccines |
| January 24 |
Researchers Find RegeneRx's TB4 Inhibits Activation of Key Inflammatory Molecule - NFkB |
| January 24 |
New Drug Therapy to Combat Graft-vs.-Host Disease in Stem-Cell Patients Shows Significant Reduction in Deaths |
| January 24 |
DCA Drug Development Company, CardioMetabolics Inc., Encouraged by Intense Public Interest in Dichloroacetate for Treatment Of Cancer |
| January 25 |
First Actemra Multinational Phase III Trial Demonstrates Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis |
| January 25 |
Phase III Actemra (tocilizumab) Study Results Demonstrate Significant Improvement in Signs and Symptoms of Patients with Rheumatoid Arthritis |
| January 25 |
DOR BioPharma to Host Conference Call on Thursday, January 25 to Discuss Recently Published orBec Phase 3 Clinical Results |
| January 25 |
Introgen Reports that INGN 241 in Combination with Avastin Results in Complete Tumor Regression |
| January 25 |
Newer Class of Antidepressants Similar in Effectiveness, But Side Effects Differ |
| January 26 |
European Association of Nuclear Medicine Journal Article Reports New Data Regarding Administration of Quadramet with Chemotherapy in Hormone Refractory Prostate Cancer Patients |
| January 26 |
The New England Journal Of Medicine Publishes Two Landmark Studies Of Noxafil (Posaconazole) in the Prevention of Invasive Fungal Infections |
| January 26 |
Chopping Off Protein Puts Immune Cells Into High Gear |
| January 26 |
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch |
| January 26 |
Chromos Reports Preclinical Data in Support of CHR-1103 as an Acute Therapy for Relapse Associated with Multiple Sclerosis |
| January 26 |
DOR BioPharma to Host Conference Call on Thursday, January 25 to Discuss Recently Published orBec(R) Phase 3 Clinical Results |
| January 26 |
Cephalon and National Cancer Institute Report Improved Survival in Newly Diagnosed Adult Patients with Acute Promyelocytic Leukemia in Study Using Trisenox |
| January 26 |
Arsenic Compound Improves Survival of Adults with Uncommon Form of Leukemia |
| January 26 |
Study Suggests Thrombolysis Therapy with Alteplase Could Be Used Routinely for Stroke Treatment |
| January 26 |
Samaritan Pharma's SP-10 Hip On Hep C |
